ACS Synthetic Biology,
Journal Year:
2024,
Volume and Issue:
13(11), P. 3746 - 3753
Published: Oct. 31, 2024
Ribosomally
synthesized
lanthionine-containing
peptides
(lanthipeptides)
have
emerged
as
a
promising
source
of
antimicrobials
against
multidrug
resistance
pathogens.
An
effective
way
to
discover
and
engineer
lanthipeptides
is
through
heterologous
expression
their
biosynthetic
gene
clusters
(BGCs)
in
host
choice.
Here
we
report
plug-and-play
pathway
refactoring
strategy
for
rapid
evaluation
lanthipeptide
BGCs
Bacillus
subtilis
based
on
the
T7
system.
As
proof
concept,
used
this
not
only
observe
successful
production
known
haloduracin
β
but
also
two
new
human-microbiota-derived
that
previously
failed
be
produced
Escherichia
coli.
The
resulting
B.
system
should
enable
genome
mining
high-throughput
manner.
Journal of Advanced Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
Antimicrobial
peptides
(AMPs)
present
a
promising
avenue
to
combat
the
growing
threat
of
antibiotic
resistance.
The
ruminant
gastrointestinal
microbiome
serves
as
unique
ecosystem
that
offers
untapped
potential
for
AMP
discovery.
We
heterologously
produced
a
type
II
lasso
peptide
gene
cluster
that
was
mined
from
Streptacidiphilus
jiangxiensis
in
E.
coli
.
Streptacidin
is
the
first
documented
to
maintain
its
3D
structure
with
methionine
as
steric
lock.
Microbial Cell Factories,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 31, 2025
Antibiotics
have
been
saving
countless
lives
from
deadly
infectious
diseases,
which
we
now
often
take
for
granted.
However,
are
currently
witnessing
a
significant
rise
in
the
emergence
of
multidrug-resistant
(MDR)
bacteria,
making
these
infections
increasingly
difficult
to
treat
hospitals.
The
discovery
and
development
new
antibiotic
has
slowed,
largely
due
reduced
profitability,
as
antibiotics
lose
effectiveness
quickly
pathogenic
bacteria
evolve
into
MDR
strains.
To
address
this
challenge,
metabolic
engineering
recently
become
crucial
developing
efficient
enzymes
cell
factories
capable
producing
both
existing
wide
range
derivatives
analogs.
In
paper,
review
recent
tools
strategies
synthetic
biology
production
antibiotics,
their
derivatives,
analogs,
along
with
representative
examples.
These
offer
promising
potential
revitalize
providing
renewed
hope
humanity's
fight
against
bacteria.
ACS Synthetic Biology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 25, 2025
Human
health
is
greatly
influenced
by
the
gut
microbiota
and
imbalance
can
lead
to
development
of
diseases.
It
widely
acknowledged
that
interaction
bacteria
within
competitive
ecosystems
their
specialized
metabolites,
which
act,
e.g.,
as
antibacterials
or
siderophores.
However,
our
understanding
occurrence
impact
such
natural
products
in
human
microbiome
remains
very
limited.
As
arylthiazole
siderophores
are
an
emerging
family
growth-promoting
molecules
pathogenic
bacteria,
we
analyzed
a
metagenomic
data
set
from
thereby
identified
bil-BGC,
originates
uncultured
Bilophila
strain.
Through
gene
synthesis
BGC
assembly,
heterologous
expression
mutasynthetic
experiments,
discovered
bilothiazoles
A–F.
While
established
activities
related
indicate
involvement
metal-binding
-uptake,
could
promote
growth
strains,
also
found
antibiotic
activity
for
some
bilothiazoles.
This
supported
biosensor-experiments,
where
C
E
show
PrecA-suppressing
activity,
while
bilothiazole
F
induces
PblaZ,
biosensor
characteristic
β-lactam
antibiotics.
These
findings
serve
starting
point
investigating
role
pathogenicity
species
gut.
Chemical Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 21, 2025
Synthetic
biology
has
played
an
important
role
in
the
renaissance
of
natural
products
research
during
post-genomics
era.
The
development
and
integration
new
tools
have
transformed
workflow
product
discovery
engineering,
generating
multidisciplinary
interest
field.
In
this
review,
we
summarize
recent
developments
biosynthesis
from
three
different
aspects.
First,
advances
bioinformatics,
experimental,
analytical
to
identify
associated
with
predicted
biosynthetic
gene
clusters
(BGCs)
will
be
covered.
This
followed
by
extensive
review
on
heterologous
expression
bacterial,
fungal
plant
organisms.
native
host-independent
paradigm
identification,
pathway
characterization,
enzyme
is
where
synthetic
most
prominent
role.
Lastly,
strategies
engineer
pathways
for
structural
diversification
complexity
generation
discussed,
including
assembly-line
megasynthase
precursor-directed
modification,
combinatorial
biosynthesis.
Nature Communications,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 28, 2025
The
human
microbiome
produces
diverse
metabolites
that
influence
host
health,
yet
the
chemical
landscape
of
ribosomally
synthesized
and
post-translationally
modified
peptides
(RiPPs)-a
versatile
class
bioactive
compounds-remains
underexplored.
Here,
we
conduct
a
large-scale
biosynthetic
analysis
306,481
microbial
genomes
from
human-associated
microbiomes,
uncovering
broad
array
yet-to-be-discovered
RiPPs.
These
RiPPs
are
distributed
across
various
body
sites
but
show
specific
enrichment
in
gut
oral
microbiome.
Big
data
omics
reveals
numerous
RiPP
families
inversely
related
to
diseases,
suggesting
their
potential
protective
effects
on
health.
For
proof
principle
study,
apply
synthetic-bioinformatic
natural
product
(syn-BNP)
approach
chemically
synthesize
nine
autoinducing
(AIPs)
for
vitro
ex
vivo
assay.
Our
findings
reveal
five
AIPs
effectively
inhibit
biofilm
formation
disease-associated
pathogens.
Furthermore,
when
testing
microbiota
mice
with
inflammatory
bowel
disease,
observe
two
can
regulate
community
reduce
harmful
species.
highlight
vast
regulating
communities
maintaining
emphasizing
therapeutic
development.
Antimicrobial
peptides
(AMPs)
are
short,
usually
cationic
with
an
amphiphilic
structure,
which
allows
them
to
easily
bind
and
interact
the
cellular
membranes
of
viruses,
bacteria,
fungi,
other
pathogens.
Bacterial
AMPs,
or
bacteriocins,
can
be
produced
from
Gram-negative
Gram-positive
bacteria
via
ribosomal
synthesis
eliminate
competing
organisms.
AMPs
vital
in
addressing
increasing
antibiotic
resistance
various
pathogens,
potentially
serving
as
alternative
ineffective
antibiotics.
Bacteriocins
have
a
narrow
spectrum
action,
making
highly
specific
antibacterial
compounds
that
target
particular
bacterial
This
review
covers
two
main
groups
bacteriocins
by
their
modes
classification,
sources
positive
effects
they
play
on
human
body,
limitations
future
perspectives
Food & Function,
Journal Year:
2024,
Volume and Issue:
15(12), P. 6743 - 6758
Published: Jan. 1, 2024
Soyasaponins,
recognized
for
their
anti-inflammatory
and
antioxidant
effects,
have
not
yet
been
fully
explored
role
in
combating
enterotoxigenic
Escherichia
coli
(ETEC)
infections.